07/28/2025 10:38 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) Iroquois Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
07/21/2025 10:16 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
07/16/2025 3:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2025 8:18 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B4 | |
07/15/2025 11:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form EFFECT | |
07/10/2025 4:29 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1/A | |
07/09/2025 12:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1/A | |
07/08/2025 3:46 PM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form FWP | |
07/08/2025 3:08 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
06/18/2025 7:27 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2025 3:34 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for BCTXW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
05/13/2025 8:08 PM | 3i, LP (Filed by) BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/01/2025 9:01 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G | |
04/28/2025 3:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2025 8:06 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B4 | |
04/28/2025 8:07 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B4 | |
04/24/2025 11:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form EFFECT | |
04/24/2025 4:11 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1MEF | |
04/24/2025 3:41 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form CERT | |
04/24/2025 2:46 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-A12B | |
04/23/2025 3:51 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1/A | |
04/22/2025 3:26 PM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form FWP | |
02/10/2025 8:02 PM | 3i, LP (Filed by) BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025 3:30 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2025 4:02 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 3:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
02/03/2025 3:37 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
12/17/2024 3:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form DEF 14A | |
12/13/2024 3:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2024 4:27 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
12/12/2024 5:06 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
12/11/2024 4:21 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
12/10/2024 5:06 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
12/05/2024 6:45 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
11/14/2024 11:17 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SC 13G/A | |
11/01/2024 3:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2024 9:12 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
10/01/2024 3:02 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 9:22 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SC 13G | |
09/12/2024 3:25 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 7:50 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Elon Musk’s New Technology (Ad) Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation.
You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth. Get the full details on the AI company behind Musk’s next big move. |
09/11/2024 7:50 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2024 4:00 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |